Table 2. Proportion of patients with comorbidities and medication at start of KRT according to primary kidney disease.

%	Type 2 diabetes	Type 1 diabetes	Glomerulo–nephritis	Polycystic kidney disease	Nephro–sclerosis	Other or unknown diagnoses	All patients	P value
Coronary artery disease	41.2	24.5	14.1	10.7	39.2	22.3	25.2	<0.001
Peripheral vascular disease	28.8	20.2	4.7	4.2	25.2	10.2	15.0	<0.001
Left ventricular hypertrophy	48.3	33.2	26.4	21.9	51.3	27.2	33.0	<0.001
Cerebrovascular disease	16.9	11.9	9.0	9.6	15.5	8.6	11.3	<0.001
Heart failure	19.5	7.3	5.2	2.1	14.2	10.7	10.5	<0.001
Malignancy	9.9	3.5	8.0	6.5	14.3	19.8	12.1	<0.001
One comorbidity a	30.1	29.4	27.4	27.4	33.3	32.2	30.3	<0.001
Two comorbidities a	24.2	15.4	10.6	8.9	21.7	14.9	16.1	<0.001
Three or more comorbidities a	22.6	10.8	4.9	2.7	22.4	10.0	12.0	<0.001
Obesity (BMI > 30 kg/m 2 )	47.5	16.4	23.1	17.4	19.1	16.7	23.9	<0.001
Underweight (BMI < 20 kg/m 2 )	1.8	6.5	6.4	4.2	4.8	8.6	6.0	<0.001
Systolic blood pressure > 140 mmHg	72.4	76.7	68.3	62.6	69.7	56.4	65.7	<0.001
Diastolic blood pressure > 90 mmHg	15.5	31.0	35.5	31.2	22.6	20.2	24.3	<0.001
Medication for hypertension	95.0	96.6	94.0	92.5	95.6	78.2	88.9	<0.001
Medication for dyslipidemia	73.7	71.5	55.2	45.4	58.4	38.0	54.6	<0.001

BMI, body mass index.

^aOf the six comorbidities above.